| Literature DB >> 26776937 |
Megan E V Caram1, Ted A Skolarus2, Kathleen A Cooney3.
Abstract
Prostate-specific antigen (PSA) is frequently used in isolation to guide treatment decisions in men with recurrent prostate cancer, a practice discouraged by prostate cancer working groups and guidelines. Instead, PSA should be used with imaging and other factors to make treatment decisions. Published by Elsevier B.V.Entities:
Mesh：
Substances：
Year: 2016 PMID： 26776937 DOI： 10.1016/j.eururo.2015.12.045
Source DB: PubMed Journal: Eur Urol ISSN： 0302-2838 Impact factor: 20.096